0000950103-15-004569.txt : 20150603 0000950103-15-004569.hdr.sgml : 20150603 20150603193509 ACCESSION NUMBER: 0000950103-15-004569 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150601 FILED AS OF DATE: 20150603 DATE AS OF CHANGE: 20150603 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001411158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251854385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 650-543-7500 MAIL ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 FORMER COMPANY: FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc DATE OF NAME CHANGE: 20070830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bell Graeme CENTRAL INDEX KEY: 0001643757 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34973 FILM NUMBER: 15911573 MAIL ADDRESS: STREET 1: 1324 WAVERLY ROAD CITY: GLADWYNE STATE: PA ZIP: 19035 4 1 dp56647_4-graeme.xml FORM 4 X0306 4 2015-06-01 0 0001411158 Anacor Pharmaceuticals, Inc. ANAC 0001643757 Bell Graeme C/O ANACOR PHARMACEUTICALS, INC. 1020 EAST MEADOW CIRCLE PALO ALTO CA 94303 0 1 0 0 Executive VP and CFO Common Stock 2015-06-01 4 A 0 6006 0 A 6006 D Stock Option (right to buy) 69.34 2015-06-01 4 A 0 28793 0 A 2025-06-01 Common Stock 28793 28793 D Performance Restricted Stock Units 2015-06-01 4 A 0 8008 0 A Common Stock 8008 8008 D Performance Restricted Stock Units 2015-06-01 4 A 0 4004 0 A Common Stock 4004 4004 D Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is June 1, 2015. The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting each month thereafter. The Vesting Commencement Date is June 1, 2015. Represents performance restricted stock units granted to the Reporting Person. Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. In the event that the volume-weighted average price of the Issuer's Common Stock equals or exceeds (i) $80.00 per share for 30 consecutive trading days prior to January 1, 2016 or (ii) $100.00 per share for 30 consecutive trading days prior to January 1, 2017, the shares subject to the award shall vest in two equal annual installments following the date on which the condition specified in clause (i) or (ii) is met. Represents performance restricted stock units granted to the Reporting Person. Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. In the event that the volume-weighted average price of the Issuer's Common Stock equals or exceeds (i) $80.00 per share for 30 consecutive trading days prior to January 1, 2017, 50% of the shares subject to the award shall vest in two equal annual installments following the date on which the condition specified in this clause (i) is met, and (ii) $100.00 per share for 30 consecutive trading days prior to January 1, 2017, the remaining 50% of the shares subject to the award shall vest in two equal annual installments following the date on which the condition specified in this clause (ii) is met. /s/ Ryan T. Sullivan, as attorney-in-fact 2015-06-03